Circle Pharma Secures $92.5 Million in Series E Financing

Wilson Sonsini Goodrich & Rosati has advised Circle Pharma. Circle Pharma, Inc., a clinical-stage biopharmaceutical company specializing in targeted macrocycle therapeutics for cancer, has announced the…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here